Literature DB >> 9362359

Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors.

K Kubota1, M Makuuchi, K Kusaka, T Kobayashi, K Miki, K Hasegawa, Y Harihara, T Takayama.   

Abstract

The respective volumes of hepatic tumors and nontumorous parenchyma of 50 patients requiring hepatectomy of more than one segment of Healey for tumor removal were measured using computed tomography (Vol-CT). The volume estimated by Vol-CT was found to correlate with the real weight resected (P < .0001) with a mean absolute error of 64.9 mL. The ratio of the nontumorous parenchymal volume of the resected liver to that of the whole liver (R2) in 15 patients who underwent right or extended right hepatic lobectomy was 43% +/- 15%. Eight of 15 patients with R2s < 60% underwent the procedures without right portal vein embolization (PE). The other seven with R2s exceeding 60% or an indocyanine green retention rate after 15 minutes (ICG15) of 10% to 20% underwent PE: in six of seven, the nontumorous parenchyma of the right hepatic lobe became atrophic and in all seven, the volume of the remaining left hepatic lobe increased with a decrease in the mean R2 from 62% +/- 14% to 55% +/- 8% (P = .0006). In the remaining 35 who underwent other hepatectomy procedures, R2s also remained <60%. Overall, at surgery, in 27 with normal liver function (ICG15 < 10%), R2s exceeded 60% in one, remained at 50% to 60% in five, and <50% in 21, whereas 23 patients except for one with an ICG15 exceeding 10%, had R2s of <50%. The postoperative serum total bilirubin levels in 84% of the patients remained within the normal range and there was no surgery-related mortality. In conclusion, 1) Vol-CT can accurately assess the extent of liver resection, 2) individuals with normal liver function can undergo resection of up to 60% of the nontumorous parenchyma without the need for PE, and 3) PE can be used to reduce the size of the resected tissue and increase the volume of the remnant liver to approximate the target limits in individuals with large tumors or minimally abnormal liver function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362359     DOI: 10.1053/jhep.1997.v26.pm0009362359

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  223 in total

1.  Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Authors:  Ronnie Tung Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Kei Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

2.  [Living donor liver transplantation].

Authors:  K Tanaka; S Kaihara
Journal:  Chirurg       Date:  2003-10       Impact factor: 0.955

3.  Safe and permissible limits of hepatectomy in obstructive jaundice patients.

Authors:  Tetsuya Takahashi; Shinji Togo; Kuniya Tanaka; Itaru Endo; Yoshiro Fujii; Hiroshi Shimada
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

Review 4.  Protection of the liver during hepatic surgery.

Authors:  Pierre-Alain Clavien; Jean Emond; Jean Nicolas Vauthey; Jacques Belghiti; Ravi S Chari; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

5.  Formula for calculating standard liver volume in Indians.

Authors:  Anuradha Chandramohan; Banumathi Ramakrishna; Sitaram Venkatramani
Journal:  Indian J Gastroenterol       Date:  2012-02-21

6.  Estimate or calculate? How surgeons rate volumes and surfaces.

Authors:  Jochen Schuld; Otto Kollmar; Roland Seidel; Catherine Black; Martin K Schilling; Sven Richter
Journal:  Langenbecks Arch Surg       Date:  2012-03-17       Impact factor: 3.445

7.  Pretreatment assessment of hepatocellular cancer: expert consensus conference.

Authors:  Stephanie R Wilson; Paul Greig; Ahmed O Kaseb
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

8.  A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases.

Authors:  Daniel Jaeck; Elie Oussoultzoglou; Edoardo Rosso; Michel Greget; Jean-Christophe Weber; Philippe Bachellier
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

Review 9.  Portal vein embolization in extended liver resection.

Authors:  Nisha Narula; Thomas A Aloia
Journal:  Langenbecks Arch Surg       Date:  2017-05-31       Impact factor: 3.445

10.  [Mesohepatectomy-an alternative to extended hepatectomy in the treatment of central liver tumors].

Authors:  H Lang; G C Sotiropoulos; N R Frühauf; A Radtke; M Malagó; Ch E Broelsch
Journal:  Chirurg       Date:  2004-03-12       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.